Reported 11 months ago
Truist Securities has upgraded Krispy Kreme's recommendation to buy from hold, citing Americans' unwavering love for doughnuts amidst the rise of weight-loss drugs. Analysts believe the impact of GLP-1s on snack companies is already factored into Krispy Kreme's valuation and anticipate steady growth for the brand, especially with its new partnership with McDonald's. Despite concerns over sugary snacks due to weight-loss drugs, Krispy Kreme is seen as well-positioned to thrive in the indulgent snack category, with shares rising in response to the upgrade.
Source: YAHOO